Environmental

OGEN provides no disclosed environmental operating metrics in the supplied data, leaving peer-relative assessment constrained versus better-disclosed biotechnology peers.

Zero reported R&D intensity in the provided metrics suggests limited evidence of environmental process disclosure, while peers typically provide clearer sustainability-related operational transparency.

The absence of emissions, energy, water, and waste disclosures weakens comparability against peers that report these material biotech environmental indicators more comprehensively.

No environmental controversies are provided, so the company appears neither advantaged nor structurally disadvantaged versus peers on disclosed environmental risk management.

Social

The supplied data show no social KPIs, so OGEN cannot demonstrate peer-leading workforce, safety, or community practices through disclosed metrics.

Zero stock-based compensation in the metrics may indicate limited disclosure on employee alignment, whereas peers often provide more visible retention and incentive structures.

No human-capital, product-safety, or access-related disclosures are provided, reducing confidence that OGEN matches peers on the social factors most material to biotech.

The absence of reported social controversies prevents a weaker score, but limited transparency leaves OGEN broadly in line with lower-disclosure peers rather than ahead.

Governance

The company shows no debt-to-equity leverage in the supplied metrics, which supports balance-sheet simplicity relative to more levered peers.

Net debt to EBITDA of 0.54 suggests modest leverage, but peers with stronger capital discipline and clearer governance disclosures may still compare more favorably.

Zero stock-based compensation in the metrics may indicate limited dilution pressure, yet the absence of broader board and ownership disclosures constrains governance differentiation.

No governance controversies are provided, so OGEN appears operationally stable, but disclosure depth remains below stronger-reporting peers.

Overall Score

OGEN ranks as a moderate ESG peer because it lacks the disclosure depth and material KPI transparency that stronger biotech peers use to demonstrate leadership.

Score Driver: Limited ESG Disclosure Across Environmental, Social, And Governance Dimensions Versus Peers